Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology

Case Report

Published on 29 Jan 2025

From the right ventricle to the descending aorta: a Case Report of complex thrombotic events in a patient with nephrotic syndrome

in Cardiovascular and Smooth Muscle Pharmacology

Jiaojiao Chen
Longyin Zhu
Fen Zhou
Yuting Li
Tao Gu
Jing Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1514801

1,217 views

Original Research

Published on 27 Jan 2025

Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation

in Cardiovascular and Smooth Muscle Pharmacology

Ai-Li Xu
Zheng Shen
Shi-Hao Wang
Hai-Yun Luan
Yong Xu
Ze-Chun Kang
Zi-Qi Liao
Jie Liu
Xiao-Lei Duan
Wei-Hua Bian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1496380

1,216 views
1 citation

Original Research

Published on 27 Jan 2025

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system

in Cardiovascular and Smooth Muscle Pharmacology

Jingrong Yang
Mengfan You
Jingxin Wang
Rongfei Sun
Lili Han
Xiaonan Liu
Kaibin Niu
Kaidi Xing
Juanping Sun
Wenge Su

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1517616

1,954 views

Correction

Published on 22 Jan 2025

Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling

in Cardiovascular and Smooth Muscle Pharmacology

Bin Zhang
Jingyi Zhang
Chenyang Zhang
Xuelian Zhang
Jingxue Ye
Shihuan Kuang
Guibo Sun
Xiaobo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488083

913 views

Original Research

Published on 15 Jan 2025

Drug-induced heart failure: a real-world pharmacovigilance study using the FDA adverse event reporting system database

in Cardiovascular and Smooth Muscle Pharmacology

Youqi Huang
Xiaowen Chen
Mingyu Chen
Yuze Lin
Bingqi Chen
Hongjin Gao
Min Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1523136

2,457 views

Original Research

Published on 15 Jan 2025

Effect of prophylactic doses of enoxaparin on antifactor Xa activity confirmed by rotational thromboelastometry in critically ill patients: a preliminary prospective cohort study

in Cardiovascular and Smooth Muscle Pharmacology

Piotr F. Czempik
Artur Beberok

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498188

1,078 views

Original Research

Published on 13 Jan 2025

Clopidogrel combined with rivaroxaban in peripheral artery disease after revascularization

in Cardiovascular and Smooth Muscle Pharmacology

Min Lu
Jiaqi Li
Huanyu Ni
Tong Qiao
Baoyan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485380

2,313 views

Original Research

Published on 10 Jan 2025

Assembly of ceria-Nrf2 nanoparticles as macrophage-targeting ROS scavengers protects against myocardial infarction

in Cardiovascular and Smooth Muscle Pharmacology

Wenjing Liao
Jinduan Lin
Wenli Wang
Ming Zhang
Yanfang Chen
Xin Li
Huan Liu
Pan Xia Wang
Guojun Zhao
Jijun Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503757

1,480 views
1 citation

Review

Published on 10 Jan 2025

Interplay between energy metabolism and NADPH oxidase-mediated pathophysiology in cardiovascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Haipeng Jie
Jingjing Zhang
Shuzhen Wu
Luyao Yu
Shengnan Li
Bo Dong
Feng Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503824

1,996 views
1 citation

Original Research

Published on 07 Jan 2025

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis

in Cardiovascular and Smooth Muscle Pharmacology

Aleksandra Antonczyk
Katarzyna Kluzek
Natalia Herbich
Mahdi Eskandarian Boroujeni
Bart Krist
Dorota Wronka
Anna Karlik
Lukasz Przybyl
Adam Plewinski
Joanna Wesoly

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1471182

2,772 views
1 citation

Review

Published on 07 Jan 2025

Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease

in Cardiovascular and Smooth Muscle Pharmacology

Xiao-Lan Zhao
Zhang-Jing Cao
Ke-Di Li
Fei Tang
Li-Yue Xu
Jing-Nan Zhang
Dong Liu
Cheng Peng
Hui Ao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1515172

2,422 views
1 citation

Editorial

Published on 07 Jan 2025

Editorial: Chronobiology in cardiometabolic health and disease

in Cardiovascular and Smooth Muscle Pharmacology

Cristina Manuela Dragoi
Zhihong Yang
Baharan Fekry
Andrea Brenna

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1544963

1,024 views
1 citation

Editorial

Published on 06 Jan 2025

Editorial: Insights in cardiovascular and smooth muscle pharmacology: 2023

in Cardiovascular and Smooth Muscle Pharmacology

Sönke Schildt
Daniel Reichart
Simon Lebek

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1544594

1,170 views

Editorial

Published on 06 Jan 2025

Editorial: Revealing the unconventional mechanisms of mitochondria-targeting drugs in heart-related diseases

in Cardiovascular and Smooth Muscle Pharmacology

Kaidi Ren
Yang Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1543291

663 views

Original Research

Published on 03 Jan 2025

Assessing the relationships of 1,400 blood metabolites with abdominal aortic aneurysm: a Mendelian randomization study

in Cardiovascular and Smooth Muscle Pharmacology

Qian Guo
Xinghua Xu
Xiaohui Li
Yang Mao
Shengqiang Li
Yuxin Yao
Xiang Li
Yaxing Li
Jiayue Feng
Yan Shu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1514293

1,811 views

Original Research

Published on 03 Jan 2025

Cardioprotective effects of the electrolyte solution sterofundin and the possible underlying mechanisms

in Cardiovascular and Smooth Muscle Pharmacology

Min Chen
Yingying Xiao
Jijian Zheng
Peibin Zhao
Lin Cheng
Chuan Jiang
Sixie Zheng
Zheng Wang
Sijuan Sun
Lincai Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1449831

1,301 views